BCL2 and diffuse large B-cell lymphoma: Our previous study on SOX9 expression in a large number of DLBCL patient samples revealed high SOX9 expression in a subset of patients with GCB DLBCL harbouring the IGH/BCL2 translocation, which frequently results in elevated BCL2 expression.